Impact of Aromatherapy on Nausea in Hospitalized Children Undergoing Rehabilitation
1 other identifier
observational
10
1 country
1
Brief Summary
Children, ages 8 - 17, will be enrolled in a research study about the impact of aromatherapy on nausea in the pediatric rehabilitation unit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2023
CompletedFirst Posted
Study publicly available on registry
August 24, 2023
CompletedStudy Start
First participant enrolled
January 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
ExpectedJuly 18, 2024
July 1, 2024
2.3 years
August 18, 2023
July 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Wellbeing
Is there an improvement in overall wellbeing as evidenced by a rate of change in nausea with the implementation of aromatherapy in pediatric patients on an inpatient rehabilitation unit? The Baxter Animated Retching Faces (BARF) scale will be used along with a patient diary where patients record how they are feeling. The BARF scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).
Two week duration
Secondary Outcomes (2)
Symptoms of Nausea
Two week duration
Change in Nausea
Two week duration
Study Arms (1)
Aromatherapy
Randomized crossover research study
Interventions
Study participants will participate in one week with aromatherapy treatment and one week without aromatherapy treatment (randomly ordered) to serve as their own control.
Eligibility Criteria
The study will be conducted on a 10 bed pediatric rehabilitation unit at Arkansas Children's Hospital. The goals of inpatient rehabilitation are to assist patients in reaching their greatest level of independence and to maximize each child's recovery. Admission criteria include: 1) a medically stable patient who is able and willing to actively participate in 3 hours of therapy (combined time for occupational, physical and speech therapy) per day, 6 days a week; 2) a diagnosis where the patient is expected to benefit from a comprehensive inpatient interdisciplinary rehabilitation program; and, 3) established goals that are specific and pertain to improving functional independence. The top three diagnoses for children admitted to the rehabilitation unit include ABI, TBI, and spinal cord injury. Other diagnoses include, but are not limited to, amputation, burn injury, and cerebral palsy.
You may qualify if:
- Patients ages 8 to 17 years of age on the rehabilitation unit and service at Arkansas Children's Hospital
- Patients with a Glascow Coma Scale (GCS) of 13-15
- Patients with a Rancho Los Amigos Revised Scale score of 5 or higher
- Ability to read and write in English
- Patient to have an expected length of stay of at least 2 weeks
You may not qualify if:
- Patients with any mechanical or obstructive pathophysiology (appendicitis, bowel obstruction, or intussusception, etc.)
- Known allergy or sensitivity to lavender, peppermint, spearmint, or ginger
- Patients with known asthma and/or pulmonary conditions
- Wards of the State or any other agency or institution
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
Related Publications (7)
Arruda J, Yeh AM. Integrative Approach to Pediatric Nausea. Pediatr Ann. 2019 Jun 1;48(6):e236-e242. doi: 10.3928/19382359-20190517-01.
PMID: 31185115BACKGROUNDBaxter AL, Watcha MF, Baxter WV, Leong T, Wyatt MM. Development and validation of a pictorial nausea rating scale for children. Pediatrics. 2011 Jun;127(6):e1542-9. doi: 10.1542/peds.2010-1410. Epub 2011 May 29.
PMID: 21624874BACKGROUNDBrown L, Danda L, Fahey TJ 3rd. A Quality Improvement Project to Determine the Effect of Aromatherapy on Postoperative Nausea and Vomiting in a Short-Stay Surgical Population. AORN J. 2018 Oct;108(4):361-369. doi: 10.1002/aorn.12366.
PMID: 30265393BACKGROUNDCzarnecki ML, Michlig JR, Norton AM, Stelter AJ, Hainsworth KR. Use of Aromatherapy for Pediatric Surgical Patients. Pain Manag Nurs. 2022 Dec;23(6):703-710. doi: 10.1016/j.pmn.2022.08.003. Epub 2022 Sep 16.
PMID: 36123297BACKGROUNDMarsh E, Millette D, Wolfe A. Complementary Intervention in Postoperative Care: Aromatherapy's Role in Decreasing Postoperative Nausea and Vomiting. J Holist Nurs. 2022 Dec;40(4):351-358. doi: 10.1177/08980101211065555. Epub 2021 Dec 15.
PMID: 34905993BACKGROUNDSanchez FA, Rosales JR, Godoy PR, Barria RM. Effects of inhalation aromatherapy as a complementary therapy in pediatric patients in the clinical practice: A systematic review. Complement Ther Clin Pract. 2022 Feb;46:101516. doi: 10.1016/j.ctcp.2021.101516. Epub 2021 Nov 23.
PMID: 34837806BACKGROUNDWeaver MS, Robinson J, Wichman C. Aromatherapy improves nausea, pain, and mood for patients receiving pediatric palliative care symptom-based consults: A pilot design trial. Palliat Support Care. 2020 Apr;18(2):158-163. doi: 10.1017/S1478951519000555.
PMID: 31423959BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laikin Ulrich, BSN
Arkansas Children's Hospital Research Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Submitted on behalf of Laikin Ulrich, RN IV Care Coordinator, Acute Care Rehabilitation
Study Record Dates
First Submitted
August 18, 2023
First Posted
August 24, 2023
Study Start
January 23, 2024
Primary Completion
May 1, 2026
Study Completion (Estimated)
May 1, 2027
Last Updated
July 18, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share